News
A proof-of-concept study will test VAS-101, a topical gel using the turmeric extract curcumin, in sickle cell disease (SCD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback